Roulhwai Chen

Title: Roulhwai Chen: Innovator in Erythrocyte Sedimentation Rate Control

Introduction

Roulhwai Chen is a notable inventor based in San Jose, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in the development of erythrocyte sedimentation rate (ESR) controls. With a total of 3 patents to his name, Chen's work has been instrumental in enhancing the accuracy and precision of analytical methods used in clinical settings.

Latest Patents

One of Roulhwai Chen's latest patents focuses on a three-phase suspension suitable for use as an erythrocyte sedimentation rate (ESR) control. This innovative control comprises three key components: (1) a synthetic plasma base, (2) an aggregating agent such as a high molecular weight polymer or a combination of high molecular weight polymers, and (3) chemically fixed mammalian red blood cells. The design of this control allows users to effectively monitor the accuracy and precision of analytical methods for determining the sedimentation rate of human erythrocytes in whole blood specimens. The chemical fixing of the red blood cells enhances the ESR control's capability to provide useful results even in the presence of citrate and/or saline.

Career Highlights

Throughout his career, Roulhwai Chen has worked with various companies, including Hycor Biomedical, LLC. His experience in these organizations has contributed to his expertise in the field of medical diagnostics and innovation.

Collaborations

Roulhwai Chen has collaborated with professionals in his field, including his coworker Azra S Zaidi. These collaborations have likely fostered the exchange of ideas and advancements in their respective areas of expertise.

Conclusion

Roulhwai Chen's contributions to the field of erythrocyte sedimentation rate control demonstrate his commitment to improving medical diagnostics. His innovative patents and collaborations highlight his role as a significant inventor in this important area of healthcare.